Answer
Belatacept binds to CD80 and CD86 on antigen-presenting cells, blocking CD28-mediated co-stimulation of T cells and thereby inhibiting their activation.
Sources for this answer
- NULOJIX 250 mg powder for concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 18Document updated
Sources checked